• 1
    Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller R. Functional bowel disorders. Gastroenterology 2006; 130: 148091.
  • 2
    Drossman DA, Li Z, Andruzzi E, et al. US House-holder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci 1993; 38: 156980.
  • 3
    Thompson WG. A world view of IBS. In: SpillerR, CamilleriM eds. The Irritable Bowel Syndrome, Diagnosis and treatment. Edinburgh: WB Saunders, 2002: 1726.
  • 4
    Longstreth GF. Definition and classification of IBS: current consensus and controversies. Gastroenterol Clin North Am 2005; 34: 17387.
  • 5
    Longstreth GF, Bolus R, Naliboff B, et al. Impact of irritable bowel syndrome on patient lives: development and psychometric documentation of disease-specific measure for use in clinical trials. Eur J Gastroenterol Hepatol 2005; 17: 41120.
  • 6
    Wilson A, Longstreth G, Knight K, et al. Quality of life in managed care patients with irritable bowel syndrome. Manag Care Interface 2004; 17: 248.
  • 7
    Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 177098.
  • 8
    Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel syndrome. Br Med J 1978; 2: 6534.
  • 9
    Maxton DG, Morris JA, Whorwell PJ. Ranking of symptoms by patients with irritable bowel syndrome. Br Med J 1989; 299: 1138.
  • 10
    Schmulson M, Lee O-Y, Chang L, Naliboff B, Mayer EA. Symptom difference in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999; 94: 292935.
    Direct Link:
  • 11
    Lee O-Y, Mayer EA, Schmulson M, Chang L, Naliboff B. Gender-related differences in IBS symptoms. Am J Gastroenterol 2001; 96: 218493.
    Direct Link:
  • 12
    Chang L, Lee O-Y, Naliboff B, Schmulson M, Mayer EA. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol 2001; 96: 33417.
    Direct Link:
  • 13
    Hungin APS, Whorwell PJ, Tack J, Mearins F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17: 64350.
  • 14
    Sandler RS, Stewart WF, Liberman JN, Ricci JA, Zorich NL. Abdominal pain, bloating, and diarrhoea in the United States. Prevalence and impact. Dig Dis Sci 2000; 45: 116671.
  • 15
    Talley NJ, Dennis EH, Schettler-Duncan VA, Lacey BE, Olden RW, Cromwell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation and diarrhoea. Am J Gastroenterol 2003; 98: 24549.
    Direct Link:
  • 16
    Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999; 94: 13206.
    Direct Link:
  • 17
    Maxton DG, Whorwell PJ. Abdominal distension in irritable bowel syndrome: the patients’ perspective. Eur J Gastroenterol Hepatol 1992; 4: 2413.
  • 18
    Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ. Relationship of abdominal bloating to distension in irritable bowel syndrome and effect of bowel habit. Gastroenterology 2006; 131: 100310.
  • 19
    Agrawal A, Whorwell PJ, Houghton LA. Is abdominal distension related to delayed small and large bowel transit in patients with constipation predominant irritable bowel syndrome. Gastroenterology 2006; 130 (No 4, Suppl. 2) A93, 632.
  • 20
    O’Leary C, Quigley EMM. Small bowel bacterial overgrowth, celiac disease and IBS: what are the associations? Am J Gastroenterol 2003; 98: 7202.
    Direct Link:
  • 21
    Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal micobial population in the irritable bowel syndrome. Microbiologica 1982; 5: 18594.
  • 22
    Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 37382.
    Direct Link:
  • 23
    Matto J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome – a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005; 43: 21322.
  • 24
    Maukonen J, Satokari R, Matto J, Soderlund H, Matilla-Sandholm T, Saarela M. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006; 55: 62533.
  • 25
    Pimentel M, Chow EJ, Lin HC. Normalisation of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo controlled study. Am J Gastroenterol 2003; 98: 4129.
  • 26
    Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 2003; 48: 8692.
  • 27
    Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Gastroenterol 2006; 6: G108995.
  • 28
    Verdu EF, Bercik P, Bergonzelli GE, et al. Lactobacillus paracasei normalizes muscle hyperconstractility in murine model of postintective gut dysfunction. Gastroenterology 2004; 127: 82637.
  • 29
    Massi V, Ioan P, Budriesi R, et al. The effects of probiotic bacteria on spontaneous contraction of isolated guinea pig intestine. Gastroenterology 2004; 126 (No 4, Suppl. 2): A-517, T1813.
  • 30
    Marteau P, Cuillerier E, Meance S, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomised, controlled study. Aliment Pharmacol Ther 2002; 16: 58793.
  • 31
    Meance S, Cayuela C, Raimondi A, et al. Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt strains on gut transit time in the elderly. Microb Ecol Health Dis 2003; 15: 1522.
  • 32
    Bouvier M, Meance S, Bouley C, et al. Effects of consumptionn of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit times in healthy humans. Bioscience Microflora 2001; 20: 438.
  • 33
    Meance S, Cayuela C, Turchet P, et al. A fermented milk with a bifidobacterium probiotic strain DN-173 010 shortened oro-fecal gut transit time in elderly. Microb Ecol Health Dis 2001; 13: 21722.
  • 34
    Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005; 17: 68796.
  • 35
    Quigley EM, Plourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 2007; 19: 16672.
  • 36
    Parkes GC, Brostoff J, Whelan K, Sanderson JD. Gastroinestinal microbiota in irriable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol 2008; 103: 155767.
    Direct Link:
  • 37
    Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomised, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 47586.
  • 38
    Drossman DA, Camilleri M, Mayer EA. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 210831.
  • 39
    Houghton LA, Lea R, Jackson N, Whorwell PJ. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 2002; 50: 4714.
  • 40
    Wald A, Van Theil DH, Hoechstetter L, et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80: 1497500.
  • 41
    Lewis MJV, Houghton LA, Whorwell PJ. Abdominal distension in females with irritable bowel syndrome: the effect of the menopause and hormone replacement therapy. Gut 2001; 48 (Suppl. 1): A46, 168.
  • 42
    Lewis M, Reilly B, Houghton LA, Whorwell PJ. Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut 2001; 48: 21620.
  • 43
    Reilly B, Bolton M, Houghton LA, Lewis M, Whorwell PJ. A device for 24 hour ambulatory monitoring of abdominal girth using inductive plethysmography. Physiol Meas 2002; 23: 66170.
  • 44
    Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology 1987; 92: 407.
  • 45
    Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med 1969; 281: 1227.
  • 46
    Delgado-Aros S, Camilleri M, Garcia MA, Burton D, Busciglio I. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol (Gastrointestinal Liver Physiol) 2008; 295: G3828.
  • 47
    Sadik R, Abrahamsson H, Stotzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol 2003; 38: 3642.
  • 48
    Madsen JL, Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing 2004; 33: 1549.
  • 49
    Woodmansey EJ. Intestinal bacteria and ageing. J Appl Microbiol 2007; 102: 117886.
  • 50
    Heaton KW, Ghosh S, Braddon FEM. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991; 32: 739.
  • 51
    Houghton LA, Whorwell PJ. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders. Neurogastroenterol Motil 2005; 17: 50011.
  • 52
    Agrawal A, Houghton LA, Lea R, Reilly B, Whorwell PJ. Abdominal bloating and distension in irritable bowel syndrome: a role for visceral sensation. Gastroenterology 2008; 134: 18829.
  • 53
    Spiller RC. Irritable bowel syndrome: bacteria and inflammation – clinical relevance now. Curr Treat Options Gastroenterol 2007; 10: 31221.
  • 54
    O’Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom response and relationship to cytokine profiles. Gastroenterology 2005; 128: 54151.
  • 55
    Kamiya T, Wang L, Forsythe P, et al. Inhibitory effects of Lactobacillus reuteri on visceral pain indiced by colorectal distension in Sprague–Dewley rats. Gut 2008; 55: 1916.
  • 56
    Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006; 101: 158190.
    Direct Link: